Our Team
Lisa Singer, M.D., Ph.D.
Assistant Professor
Department of Radiation Oncology
Enjoys cooking, being outside, travel
Meet Dr. Singer
I am inspired by the advancing technologies and trainees that propel our field forward, and grateful for our multidisciplinary team that allows us to provide care to all of our patients.
Dr. Singer is an Assistant Professor in Radiation Oncology with clinical interests in breast cancer, lung cancer, and women’s health. She also serves as Clinical Magnetic Resonance Imaging (MRI) Director in Radiation Oncology and is board-certified in both radiation oncology and MRI safety. Prior to joining the faculty at UCSF, she worked as an attending physician at Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Harvard Medical School for three years where she served as MR Medical Director and Assistant Professor in Radiation Oncology. Dr. Singer has worked on advancing the use of MRI for the care of patients with cancer for over 10 years and continues to develop this technology for the care of patients with breast cancer, lung cancer as well as other cancers. Her research focuses on the use of imaging to improve our ability to predict tumor response to treatment and to improve image-guidance for radiotherapy. She has developed and led multiple prospective clinical trials in this space. She is also interested in developing novel methods to improve safety and education surrounding biomedical imaging and image-guided radiotherapy. Nationally, she serves on the Board of Directors for the American Board of Magnetic Resonance Safety, participates in a national MR-linac breast cancer consortium, and co-developed #NextGenBrachy, as well as national simulation-based educational workshops in radiation oncology. Together with her colleagues in medical oncology and surgery, she strives to provide exceptional, multidisciplinary care for all her patients.
 |
Education
|
 |
Professional Experience
|
 |
Awards & Honors
|
 |
ResearchNCBI: https://www.ncbi.nlm.nih.gov/myncbi/lisa.singer.1/bibliography/public/ Significant Research Highlights:Woolen SA, Shankar PR, Gagnier JJ, MacEachern MP, Singer L, Davenport MS. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis. JAMA Intern Med. December 2019. doi:10.1001/jamainternmed.2019.5284. PMID: 31816007 Talcott WJ, Miccio JA, Park HS, White AA, Kozono DE, Singer L, Sands JM, Sholl LM, Detterbeck FC, Mak RH, Decker RH, Kann BH. Rates of invasive disease and outcomes in NSCLC patients with biopsy suggestive of carcinoma in situ. Lung Cancer. 2021 07; 157:17-20. PMID: 34052704. Alban G, Cheng T, Adleman J, Buzurovic I, Pretz J, Singer L, King M, Lee L. Definitive radiotherapy for vaginal recurrence of early-stage endometrial cancer: survival outcomes and effect of mismatch repair status. Int J Gynecol Cancer. 2021 Jul; 31(7):1007-1013. PMID: 33858956. Singer L, Rosenberg SA. The Impact of MRI on Radiation Oncology Graduate Medical Education. J Am Coll Radiol. 2019;16(6):859-863. doi:10.1016/j.jacr.2018.11.030. PMID: 30737161 Bitterman DS, Cagney DN, Singer L, Nguyen PL, Catalano PJ, Mak RH. Master protocol trial design for efficient and rational evaluation of novel therapeutic oncology devices. J Natl Cancer Inst. 2019;5(1):40. doi:10.1093/jnci/djz167. PMID: 31504680 A.J. Sim, E. Kaza, L. Singer*, S.A. Rosenberg*, (co-last authors). A Review of the Role of MRI in Diagnosis and Treatment of Early Stage Lung Cancer, Clinical & Translational Radiation Oncology (2020), doi: https://doi.org/10.1016/j.ctro.2020.06.002 PMID: 32596518 Singer C, Hessling A, Kelly E, Singer L, Jones R. Clinical Characteristics Associated with Stuttering Persistence: A Meta-Analysis. J Speech Lang Hear Res. 2020 Sep 15;63(9):2995-3018.doi: 10.1044/2020_JSLHR-20-00096. Epub 2020 Aug 10. PMID: 32772868 Singer L, Marques A, Cagney D, Kaza E. MRI in Radiation Oncology After the COVID-19 Pandemic. IJROBP. 2020 Oct 1;108(2):397-399.. doi:10.1016/j.ijrobp.2020.06.043. PMID: 32890519 Damast S, Felder S, Fields E, Singer L. Feasibility of deploying a U.S. simulation-based gynecological brachytherapy educational workshop to an international setting. Brachytherapy. Nov-Dec 2020;19(6):777-782.doi: 10.1016/j.brachy.2020.09.015. Epub 2020 Nov 19. PMID: 33221261 Singer L, McLaughlin P, Alban G, Joyner M, King M, Lee L. Simulation-Based Graduate Medical Education in MR-Guided Brachytherapy for Cervical Cancer. Brachytherapy. 2020 Nov 9;S1538-4721(20)30215-4. PMID: 33183971 |